Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnósticos Rápidos (DRE) is a Spanish medical technology company dedicated to the development and distribution of in vitro diagnostic (IVD) products. Founded in 1991, the company specializes in rapid point-of-care testing solutions for infectious diseases, toxicology, cardiology, and gynecology. Their flagship product line, Rapi-Check, provides healthcare professionals with fast and accurate results to improve patient management. DRE operates primarily in the Spanish market but also maintains an international presence through various partnerships. The company's portfolio includes lateral flow assays, clinical chemistry reagents, and specialized diagnostic equipment designed for hospital and laboratory use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagnósticos Rápidos de España.